BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 15172933)

  • 1. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
    van Etten B; Brunstein F; van IJken MG; Marinelli AW; Verhoef C; van der Sijp JR; Guetens G; de Boeck G; de Bruijn EA; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2004 Jun; 11(6):598-605. PubMed ID: 15172933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases.
    van Etten B; de Wilt JH; Brunstein F; Eggermont AM; Verhoef C
    Eur J Surg Oncol; 2009 May; 35(5):539-45. PubMed ID: 18760560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated hypoxic hepatic perfusion (IHHP) using balloon catheter techniques: from laboratory to the clinic towards a percutaneous procedure.
    Eggermont AM; van IJken MG; van Etten B; van der Sijp JR; ten Hagen TL; Wiggers T; Oudkerk M; de Boeck G; de Bruijn EA
    Hepatogastroenterology; 2000; 47(33):776-81. PubMed ID: 10919031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: a clinical and pharmacologic evaluation.
    van Iersel LB; Verlaan MR; Vahrmeijer AL; van Persijn van Meerten EL; Tijl FG; Sparidans RW; Gelderblom H; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2007 Sep; 33(7):874-81. PubMed ID: 17400422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.
    Verhoef C; de Wilt JH; Brunstein F; Marinelli AW; van Etten B; Vermaas M; Guetens G; de Boeck G; de Bruijn EA; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1367-74. PubMed ID: 18239976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Bartlett DL; Puhlmann M; Fraker DL; Bachenheimer LC
    Clin Cancer Res; 2000 Aug; 6(8):3062-70. PubMed ID: 10955785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver.
    Rothbarth J; Pijl ME; Vahrmeijer AL; Hartgrink HH; Tijl FG; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Br J Surg; 2003 Nov; 90(11):1391-7. PubMed ID: 14598420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bio-chemotherapeutic strategies and the (dis) utility of hypoxic perfusion of liver, abdomen and pelvis using balloon catheter techniques.
    van Ijken MG; van Etten B; Brunstein F; ten Hagen TL; Guetens G; de Wilt JH; de Bruijn EA; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):807-16. PubMed ID: 15951150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
    Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ
    Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
    Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver.
    Alexander HR; Libutti SK; Pingpank JF; Steinberg SM; Bartlett DL; Helsabeck C; Beresneva T
    Clin Cancer Res; 2003 Dec; 9(17):6343-9. PubMed ID: 14695133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trial.
    van Ijken MG; van Etten B; Guetens G; de Bruijn EA; Ten Hagen TL; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2005 Oct; 31(8):897-904. PubMed ID: 16084053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A newly-established method of isolated hypoxic hepatic perfusion].
    Wang Xd; Yang Rj; Sun Hl; Zhang Hz
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):200-4. PubMed ID: 18458700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular isolated hepatic perfusion under pneumoperitoneum.
    Christoforidis D; Antonescu C; Horisberger J; Kosinski M; Mosimann F; Martinet O
    Eur J Surg Oncol; 2006 Feb; 32(1):113-20. PubMed ID: 16289717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II feasibility study on the combination of two different regional treatment approaches in patients with colorectal "liver-only" metastases: hepatic interstitial brachytherapy plus regional chemotherapy.
    Wieners G; Pech M; Hildebrandt B; Peters N; Nicolaou A; Mohnike K; Seidensticker M; Sawicki M; Wust P; Ricke J
    Cardiovasc Intervent Radiol; 2009 Sep; 32(5):937-45. PubMed ID: 19472000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hepatic perfusion for liver metastases of malignant melanoma.
    Rizell M; Mattson J; Cahlin C; Hafström L; Lindner P; Olausson M
    Melanoma Res; 2008 Apr; 18(2):120-6. PubMed ID: 18337648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma.
    Varghese S; Xu H; Bartlett D; Hughes M; Pingpank JF; Beresnev T; Alexander HR
    Ann Surg Oncol; 2010 Jul; 17(7):1870-7. PubMed ID: 20221901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.
    Cattel L; Buffa E; De Simone M; Cesana P; Novello S; Dosio F; Ceruti M
    Anticancer Res; 2001; 21(3C):2243-8. PubMed ID: 11501854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated hepatic perfusion for the treatment of patients with advanced liver metastases from pancreatic and gastrointestinal neuroendocrine neoplasms.
    Grover AC; Libutti SK; Pingpank JF; Helsabeck C; Beresnev T; Alexander HR
    Surgery; 2004 Dec; 136(6):1176-82. PubMed ID: 15657573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.